Leveraging resources from universities, Jiaocheng Bio has deployed full-chain services across the entire synthetic biology industry.
Against the backdrop of the synthetic biology boom, the technical route of replacing traditional chemical production, plant and animal extraction with microbial fermentation is bringing a revolution in cost and efficiency to multiple sectors including cosmetics, pharmaceuticals, and large health industries. Founded in 2016, Shanghai Jiaocheng Biotechnology Co., Ltd. targets the technical gap in the domestic supply of high-end active ingredients, and chose to settle in the Oriental Beauty Valley in Fengxian District, Shanghai. Relying on its complete supporting system, efficient and professional service system, as well as in-depth collaboration with university research teams, the company has entered the microbial synthetic biology track and built a full-chain service covering technical development to mass production implementation.
In recent years, the demand for special active ingredients in multiple downstream high-end manufacturing sectors has continued to grow. Traditional production methods have pain points such as low extraction efficiency, insufficient purity, high environmental protection costs, and unstable supply. In contrast, the route of synthetic biology that uses microbial cell factories to produce target products in a targeted manner has been verified as a greener and more efficient solution. However, core active ingredients in many domestic fields still rely on overseas imports, and there is an obvious gap in the full-chain service capability spanning from chassis cell development to mass production scaling. Jiaocheng Biotechnology came into being to fill the market gap relying on the fundamental research accumulation of the National Biochemical Engineering Technology Research Center (Shanghai) of East China University of Science and Technology. Since its establishment, Jiaocheng Biotechnology has gradually built its own R&D and production system, successively set up R&D centers and production bases in Shanghai, Yangzhong and Ningbo. Its core business covers the entire process from front-end technical development to back-end mass production delivery, and has currently provided mature technical and product support for customers in multiple downstream industries.
The core technical advantage of Jiaocheng Biotechnology lies in its full-chain capability that connects fundamental research to industrial implementation. Different from many enterprises that only focus on front-end development or are only responsible for production, Jiaocheng Biotechnology can provide customers with one-stop biotechnology solutions covering chassis microbial cell factory development, fermentation process scaling and optimization, high-end active ingredient preparation, and turnkey engineering design of production lines. Relying on the academic accumulation of the university's fundamental research platform, Jiaocheng Biotechnology has profound technical reserves in chassis cell modification and fermentation process optimization. Combined with its own mass production implementation experience, it can effectively solve the common pain point of "difficulty in scaling from laboratory to factory" in the synthetic biology sector, reducing the time cost and risk of technical implementation for customers.
In terms of market space, according to forecasts from public industry reports, the global synthetic biology market size will exceed 100 billion US dollars by 2025. The industrial microbial and high-end active ingredients sector is one of the fastest-growing sub-tracks. The demand for domestic synthetic biology products in multiple downstream sectors in China including cosmetics, pharmaceuticals, food, large health, and agriculture is being released rapidly. The full-chain service model of Jiaocheng Biotechnology can not only provide flexible technical development and small-batch ingredient supply for small and medium-sized innovative enterprises, but also provide customized production line construction solutions for large enterprises, adapting to market demands at different levels with broad room for growth.
Looking ahead, Jiaocheng Biotechnology will continue to increase its investment in technical R&D in the field of microbial synthetic biology, further optimize the mass production scaling process, expand more product pipelines of high value-added active ingredients, and deepen cooperation with leading enterprises in various downstream sectors, promote more synthetic biology technical achievements to move from the laboratory to the market, and gradually build a leading domestic platform for microbial fermentation technology and high-end ingredient supply.
The business model of Jiaocheng Biotechnology revolves around three sectors: technical development services, sales of active ingredient products, and engineering design delivery. At present, relevant businesses have achieved stable implementation, with corresponding clear revenue sources. Up to now, information such as the Jiaocheng Biotechnology team members, financing rounds, financing amount, investors, and financing time has not been disclosed to the public, and details such as early user experience are also not publicly available.
For Jiaocheng Biotechnology, the deepest insight gained from translating university technical achievements into industrial implementation is that the value of synthetic biology must ultimately fall on the actual demands of the industrial end. Only by opening up the full chain from front-end development to back-end mass production and truly solving customers' pain points can technical innovation generate actual industrial value. In the future, the company will continue to adhere to technology-driven innovation, take root in the synthetic biology sector, and contribute to the development of the domestic high-end bio-manufacturing industry.